Association among leukocyte count, mortality, and bleeding in patients with non-st-segment elevation acute coronary syndromes (from the Acute catheterization and urgent intervention triage StrategY [ACUITY] Trial)

American Journal of Cardiology

Volumn 111, Issue 9, 2013, Pages 1237-1245

  Palmerini, Tullio ^a,b,c   Généreux, Philippe ^b,c,d   Mehran, Roxana ^c,e   Dangas, George ^c,e   Caixeta, Adriano ^b,c   Riva, Diego Della ^a   Mariani, Andrea ^a   Xu, Ke ^b,c   Stone, Gregg W ^b,c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NewYork Presbyterian Hospital   (United States)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^d HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^e MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CATHETERIZATION; CONTROLLED STUDY; EMERGENCY HEALTH SERVICE; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; INVASIVE PROCEDURE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STENT THROMBOSIS;

ACUTE CORONARY SYNDROME; CARDIAC CATHETERIZATION; CORONARY ANGIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; INCIDENCE; ITALY; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEW YORK; PROGNOSIS; PROSPECTIVE STUDIES; QUEBEC; RISK FACTORS; SURVIVAL RATE; THROMBOLYTIC THERAPY; THROMBOSIS; TRIAGE;

EID: 84876735099     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.12.056     Document Type: Article

References (26)

1. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
2. M.S. Rangel-Frausto, D. Pittet, M. Costigan, T. Hwang, C.S. Davis, and R.P. Wenzel The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study JAMA 273 1995 117 123
3. D.L. Bhatt, D.P. Chew, A.M. Lincoff, M.L. Simoons, R.A. Harrington, S.R. Ommen, G. Jia, and E.J. Topol Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes Am J Cardiol 92 2003 136 140
4. M.I. Furman, J.M. Gore, F.A. Anderson, A. Budaj, S.G. Goodman, A. Avezum, J. Lopez-Sendon, W. Klein, D. Mukherjee, K.A. Eagle, O.H. Dabbous, and R.J. Goldberg Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE) Am Heart J 147 2004 42 48
5. C. Mueller, F.J. Neumann, A.P. Perruchoud, and H.J. Buettner White blood cell count and long term mortality after non-ST elevation acute coronary syndrome treated with very early revascularisation Heart 89 2003 389 392
6. M.S. Sabatine, D.A. Morrow, C.P. Cannon, S.A. Murphy, L.A. Demopoulos, P.M. DiBattiste, C.H. McCabe, E. Braunwald, and C.M. Gibson Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18 trial) substudy J Am Coll Cardiol 40 2002 1761 1768
7. G.W. Stone, M. Bertrand, A. Colombo, G. Dangas, M.E. Farkouh, F. Feit, A.J. Lansky, A.M. Lincoff, R. Mehran, J.W. Moses, M. Ohman, and H.D. White Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale Am Heart J 148 2004 764 775
8. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, and P.W. Serruys Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
9. J. Aoki, A.J. Lansky, R. Mehran, J. Moses, M.E. Bertrand, B.T. McLaurin, D.A. Cox, A.M. Lincoff, E.M. Ohman, H.D. White, H. Parise, M.B. Leon, and G.W. Stone Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation 119 2009 687 698
10. I. Karabinos, S. Koulouris, A. Kranidis, S. Pastromas, N. Exadaktylos, and A. Kalofoutis Neutrophil count on admission predicts major in-hospital events in patients with a non-ST-segment elevation acute coronary syndrome Clin Cardiol 32 2009 561 568
11. G. Huang, X.N. Zhong, B. Zhong, Y.Q. Chen, Z.Z. Liu, L. Su, Z.Y. Ling, H. Cao, and Y.H. Yin Significance of white blood cell count and its subtypes in patients with acute coronary syndrome Eur J Clin Invest 39 2009 348 358
12. G. Ndrepepa, S. Braun, R. Iijima, D. Keta, R.A. Byrne, S. Schulz, J. Mehilli, A. Schomig, and A. Kastrati Total leukocyte count, but not C-reactive protein, predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention Clin Sci (Lond) 116 2009 651 658
13. T. Palmerini, R. Mehran, G. Dangas, E. Nikolsky, B. Witzenbichler, G. Guagliumi, D. Dudek, P. Genereux, A. Caixeta, L. Rabbani, G. Weisz, H. Parise, M. Fahy, K. Xu, B. Brodie, A. Lansky, and G.W. Stone Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trial Circulation 123 2011 2829 2837
14. M. Grzybowski, R.D. Welch, L. Parsons, C.E. Ndumele, E. Chen, R. Zalenski, and H.V. Barron The association between white blood cell count and acute myocardial infarction in-hospital mortality: findings from the National Registry of Myocardial Infarction Acad Emerg Med 11 2004 1049 1060
15. W. Hochholzer, S.D. Wiviott, E.M. Antman, C.F. Contant, J. Guo, R.P. Giugliano, A.J. Dalby, G. Montalescot, and E. Braunwald Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) Circulation 123 2011 2681 2689
16. J.W. Suh, R. Mehran, B.E. Claessen, K. Xu, U. Baber, G. Dangas, H. Parise, A.J. Lansky, B. Witzenbichler, C.L. Grines, G. Guagliumi, R. Kornowski, J. Wohrle, D. Dudek, G. Weisz, and G.W. Stone Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial J Am Coll Cardiol 58 2011 1750 1756
17. B.S. Coller Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler Thromb Vasc Biol 25 2005 658 670
18. T. Palmerini, B.S. Coller, V. Cervi, L. Tomasi, A. Marzocchi, C. Marrozzini, O. Leone, M. Piccioli, and A. Branzi Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system J Am Coll Cardiol 44 2004 1570 1577
19. T. Palmerini, M.A. Nedelman, L.E. Scudder, M.T. Nakada, R.E. Jordan, S. Smyth, R.E. Gordon, J.T. Fallon, and B.S. Coller Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates J Am Coll Cardiol 40 2002 360 366
20. M.S. Goel, and S.L. Diamond Neutrophil enhancement of fibrin deposition under flow through platelet-dependent and -independent mechanisms Arterioscler Thromb Vasc Biol 21 2001 2093 2098
21. J.K. Mickelson, N.M. Lakkis, G. Villarreal-Levy, B.J. Hughes, and C.W. Smith Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Coll Cardiol 28 1996 345 353
22. S.R. Meisel, H. Shapiro, J. Radnay, Y. Neuman, A.R. Khaskia, N. Gruener, H. Pauzner, and D. David Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction: possible implications for leukocyte aggregation and microvascular plugging J Am Coll Cardiol 31 1998 120 125
23. L.B. Becker New concepts in reactive oxygen species and cardiovascular reperfusion physiology Cardiovasc Res 61 2004 461 470
24. R. Zhang, M.L. Brennan, X. Fu, R.J. Aviles, G.L. Pearce, M.S. Penn, E.J. Topol, D.L. Sprecher, and S.L. Hazen Association between myeloperoxidase levels and risk of coronary artery disease JAMA 286 2001 2136 2142
25. R. Sharma, and S.D. Anker Immune and neurohormonal pathways in chronic heart failure Congest Heart Fail 8 2002 23 28
26. U.U. Tamhane, S. Aneja, D. Montgomery, E.K. Rogers, K.A. Eagle, and H.S. Gurm Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome Am J Cardiol 102 2008 653 657